Welcome to our dedicated page for TRANSALTA SEC filings (Ticker: TAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRANSALTA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRANSALTA's regulatory disclosures and financial reporting.
TransAlta Corporation filed a Form 6-K as a foreign private issuer that files annual reports under Form 40-F. The report, signed by Executive Vice President Finance and Chief Financial Officer Joel Hunter on September 18, 2025, includes Exhibit 99.1 titled “TransAlta to Host 2025 Investor Day.”
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 16,350,772.73 shares of TransAlta Corporation common stock, representing 5.5% of the class as of the 06/30/2025 event date.
The filing reports 0 sole voting and dispositive power and 16,350,772.73 shares of shared voting and shared dispositive power. The submission includes a joint filing agreement (Exhibit 99.1) and identifies Goldman Sachs & Co. LLC as a subsidiary that may be deemed to beneficially own the securities (Exhibit 99.2). The signatory certified the holdings are held in the ordinary course and not to influence control; signatures dated 07/17/2025.